SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 21, 16:15
3530.05
10.8 (0.31%)
VOLUME 8,580
LIVE
NSE
Nov 21, 16:15
3530.80
2.15 (0.06%)
VOLUME 119,690
Business News on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Ranbaxy sues FDA for revoking approvals for Nexium, Valcyte

2.55 pm | 18 Nov 2014 |  Source: Reuters

In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency'...

Indian drugmakers see US sales hit by delay in new nods

8.34 am | 12 Nov 2014 |  Source: Reuters

India's USD 15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year due to concerns about productio...

Dr Reddy's, Endo get FDA approval to launch generic Valcyte

11.21 am | 07 Nov 2014 |  Source: Reuters

The US Food and Drug Administration (FDA) said it has granted final approval to Indian drugmaker Dr Reddy's Laboratories and US firm Endo Internationa...

Ranbaxy loses Valcyte exclusivity: An analysis 

10.14 am | 07 Nov 2014 |  Source: CNBC-TV18

Ranbaxy has first-to-file status, meaning eligibility for six months of generic sales exclusivity for both AstraZeneca's heartburn drug Nexium & Roche...

12
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.